Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator and beta-adrenergic agonist. It is thought to act by relaxing smooth muscle, particularly in blood vessels, leading to vasodilation and improved peripheral circulation.
## Primary Indications
* Treatment of peripheral vascular disease, such as intermittent claudication.
* Adjunctive therapy in cerebrovascular insufficiency.
* *Note: Efficacy for these indications is not well-established by rigorous clinical trials.*
## Adult Dosing
* **Intermittent Claudication/Peripheral Vascular Disease:** 10 mg to 20 mg orally three to four times daily.
* **Cerebrovascular Insufficiency:** 10 mg to 20 mg orally three to four times daily.
* Maximum dose is generally considered 80 mg per day.
## Pediatric Dosing
* No established pediatric dosing. Use is not recommended.
## Dose Adjustments
* No specific dose adjustments are routinely recommended for renal or hepatic impairment, but caution is advised due to potential for accumulation.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Should not be administered intravenously.
* Use with extreme caution in patients with recent arterial bleeding or in the presence of glaucoma.
## Adverse Effects
* **Common:** Nausea, vomiting, gastrointestinal distress, dizziness, flushing, weakness, nervousness.
* **Less Common:** Hypotension, tachycardia, rash, headache, epigastric distress.
## Key Drug Interactions
* **Antihypertensives:** Isoxsuprine may potentiate the effects of antihypertensive medications, leading to hypotension.
* **Sympathomimetic agents:** Concurrent use may lead to exaggerated cardiovascular effects.
## Monitoring
* Blood pressure and heart rate.
* Signs and symptoms of peripheral vascular disease.
* Patient's response to therapy.
## Clinical Pearls
* Isoxsuprine is not a cure for peripheral vascular disease and should be used as part of a comprehensive management plan.
* Oral administration is preferred. Intravenous administration is contraindicated.
* Due to limited evidence of efficacy, consider alternative treatments with stronger clinical support.
***
**Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines before making treatment decisions. This response does not substitute for professional medical advice.
